Global Novel Coronavirus (COVID-19) Vaccine Market Size, Status and Forecast 2021-2027

Global Novel Coronavirus (COVID-19) Vaccine Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Novel Coronavirus (COVID-19) Vaccine Market Size Growth Rate by Type (2021-2027)
1.2.2 DNA
1.2.3 RNA
1.2.4 Others
1.3 Market by Application
1.3.1 Global Novel Coronavirus (COVID-19) Vaccine Market Share by Application (2021-2027)
1.3.2 Mild Symptom Patient
1.3.3 Critically Ill Patient
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Novel Coronavirus (COVID-19) Vaccine Market Size
2.2 Novel Coronavirus (COVID-19) Vaccine Market Size by Regions
2.2.1 Novel Coronavirus (COVID-19) Vaccine Growth Rate by Regions (2021-2027)
2.2.2 Novel Coronavirus (COVID-19) Vaccine Market Share by Regions (2021-2027)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 Novel Coronavirus (COVID-19) Vaccine Revenue by Players (2020-2021)
3.2 Novel Coronavirus (COVID-19) Vaccine Key Players Headquaters and Area Served
3.3 Key Players Novel Coronavirus (COVID-19) Vaccine Product/Solution/Service
3.4 Date of Enter into Novel Coronavirus (COVID-19) Vaccine Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
4.1 Global Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2021-2027)
4.2 Global Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2021-2027)
5 North America
5.1 North America Novel Coronavirus (COVID-19) Vaccine Market Forecast (2021-2027)
5.2 Novel Coronavirus (COVID-19) Vaccine Key Players in North America
5.3 North America Novel Coronavirus (COVID-19) Vaccine Market Size by Type
5.4 North America Novel Coronavirus (COVID-19) Vaccine Market Size by Application
6.4.4 Canada
6 Europe
6.1 Europe Novel Coronavirus (COVID-19) Vaccine Market Forecast (2021-2027)
6.2 Novel Coronavirus (COVID-19) Vaccine Key Players in Europe
6.3 Europe Novel Coronavirus (COVID-19) Vaccine Market Size by Type
6.4 Europe Novel Coronavirus (COVID-19) Vaccine Market Size by Application
7 Japan
7.1 Japan Novel Coronavirus (COVID-19) Vaccine Market Forecast (2021-2027)
7.2 Novel Coronavirus (COVID-19) Vaccine Key Players in Europe
7.3 Japan Novel Coronavirus (COVID-19) Vaccine Market Size by Type
7.4 Japan Novel Coronavirus (COVID-19) Vaccine Market Size by Application
8 Rest of World
8.1 China
8.1.1 China Novel Coronavirus (COVID-19) Vaccine Market Analysis
8.1.2 Key Players in China
8.2 Southeast Asia
8.2.1 Southeast Asia Novel Coronavirus (COVID-19) Vaccine Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India Novel Coronavirus (COVID-19) Vaccine Market Analysis
8.3.2 Key Players in India
9 International Player Profiles
9.1 Inovio Pharmaceuticals
9.1.1 Inovio Pharmaceuticals Company Details
9.1.2 Inovio Pharmaceuticals Description and Business Overview
9.1.3 Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine Introduction
9.1.4 Inovio Pharmaceuticals Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2020-2021)
9.1.5 Inovio Pharmaceuticals Recent Development
9.2 Takis Biotech (Evvivax)
9.2.1 Takis Biotech (Evvivax) Company Details
9.2.2 Takis Biotech (Evvivax) Description and Business Overview
9.2.3 Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine Introduction
9.2.4 Takis Biotech (Evvivax) Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2020-2021)
9.2.5 Takis Biotech (Evvivax) Recent Development
9.3 Zydus Cadila
9.3.1 Zydus Cadila Company Details
9.3.2 Zydus Cadila Description and Business Overview
9.3.3 Zydus Cadila Novel Coronavirus (COVID-19) Vaccine Introduction
9.3.4 Zydus Cadila Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2020-2021)
9.3.5 Zydus Cadila Recent Development
9.4 Codagenix, Inc.
9.4.1 Codagenix, Inc. Company Details
9.4.2 Codagenix, Inc. Description and Business Overview
9.4.3 Codagenix, Inc. Novel Coronavirus (COVID-19) Vaccine Introduction
9.4.4 Codagenix, Inc. Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2020-2021)
9.4.5 Codagenix, Inc. Recent Development
9.5 GeoVax, Inc.
9.5.1 GeoVax, Inc. Company Details
9.5.2 GeoVax, Inc. Description and Business Overview
9.5.3 GeoVax, Inc. Novel Coronavirus (COVID-19) Vaccine Introduction
9.5.4 GeoVax, Inc. Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2020-2021)
9.5.5 GeoVax, Inc. Recent Development
9.6 Bravovax
9.6.1 Bravovax Company Details
9.6.2 Bravovax Description and Business Overview
9.6.3 Bravovax Novel Coronavirus (COVID-19) Vaccine Introduction
9.6.4 Bravovax Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2020-2021)
9.6.5 Bravovax Recent Development
9.7 Janssen Pharmaceutical Companies
9.7.1 Janssen Pharmaceutical Companies Company Details
9.7.2 Janssen Pharmaceutical Companies Description and Business Overview
9.7.3 Janssen Pharmaceutical Companies Novel Coronavirus (COVID-19) Vaccine Introduction
9.7.4 Janssen Pharmaceutical Companies Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2020-2021)
9.7.5 Janssen Pharmaceutical Companies Recent Development
9.8 Altimmune
9.8.1 Altimmune Company Details
9.8.2 Altimmune Description and Business Overview
9.8.3 Altimmune Novel Coronavirus (COVID-19) Vaccine Introduction
9.8.4 Altimmune Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2020-2021)
9.8.5 Altimmune Recent Development
9.9 Vaxart
9.9.1 Vaxart Company Details
9.9.2 Vaxart Description and Business Overview
9.9.3 Vaxart Novel Coronavirus (COVID-19) Vaccine Introduction
9.9.4 Vaxart Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2020-2021)
9.9.5 Vaxart Recent Development
9.10 CanSino Biologics
9.10.1 CanSino Biologics Company Details
9.10.2 CanSino Biologics Description and Business Overview
9.10.3 CanSino Biologics Novel Coronavirus (COVID-19) Vaccine Introduction
9.10.4 CanSino Biologics Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2020-2021)
9.10.5 CanSino Biologics Recent Development
9.11 ExpreS2ion Biotechnologies ApS
9.11.1 ExpreS2ion Biotechnologies ApS Company Details
9.11.2 ExpreS2ion Biotechnologies ApS Description and Business Overview
9.11.3 ExpreS2ion Biotechnologies ApS Novel Coronavirus (COVID-19) Vaccine Introduction
9.11.4 ExpreS2ion Biotechnologies ApS Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2020-2021)
9.11.5 ExpreS2ion Biotechnologies ApS Recent Development
9.12 Clover Biopharmaceuticals
9.12.1 Clover Biopharmaceuticals Company Details
9.12.2 Clover Biopharmaceuticals Description and Business Overview
9.12.3 Clover Biopharmaceuticals Novel Coronavirus (COVID-19) Vaccine Introduction
9.12.4 Clover Biopharmaceuticals Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2020-2021)
9.12.5 Clover Biopharmaceuticals Recent Development
9.13 GSK
9.13.1 GSK Company Details
9.13.2 GSK Description and Business Overview
9.13.3 GSK Novel Coronavirus (COVID-19) Vaccine Introduction
9.13.4 GSK Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2020-2021)
9.13.5 GSK Recent Development
9.14 Vaxil Bio Ltd.
9.14.1 Vaxil Bio Ltd. Company Details
9.14.2 Vaxil Bio Ltd. Description and Business Overview
9.14.3 Vaxil Bio Ltd. Novel Coronavirus (COVID-19) Vaccine Introduction
9.14.4 Vaxil Bio Ltd. Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2020-2021)
9.14.5 Vaxil Bio Ltd. Recent Development
9.15 Generex
9.15.1 Generex Company Details
9.15.2 Generex Description and Business Overview
9.15.3 Generex Novel Coronavirus (COVID-19) Vaccine Introduction
9.15.4 Generex Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2020-2021)
9.15.5 Generex Recent Development
9.16 Novavax, Inc.
9.16.1 Company Details
9.16.2 Novavax, Inc. Description and Business Overview
9.16.3 Novavax, Inc. Novel Coronavirus (COVID-19) Vaccine Introduction
9.16.4 Novavax, Inc. Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2020-2021)
9.16.5 Novavax, Inc. Recent Development
9.17 Sanofi Pasteur
9.17.1 Sanofi Pasteur Company Details
9.17.2 Sanofi Pasteur Description and Business Overview
9.17.3 Sanofi Pasteur Novel Coronavirus (COVID-19) Vaccine Introduction
9.17.4 Sanofi Pasteur Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2020-2021)
9.17.5 Sanofi Pasteur Recent Development
9.18 Baylor
9.18.1 Baylor Company Details
9.18.2 Baylor Description and Business Overview
9.18.3 Baylor Novel Coronavirus (COVID-19) Vaccine Introduction
9.18.4 Baylor Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2020-2021)
9.18.5 Baylor Recent Development
9.18 iBio, Inc.
.1 iBio, Inc. Company Details
.2 iBio, Inc. Description and Business Overview
.3 iBio, Inc. Novel Coronavirus (COVID-19) Vaccine Introduction
.4 iBio, Inc. Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2020-2021)
.5 iBio, Inc. Recent Development
9.20 Moderna, Inc.
9.20.1 Moderna, Inc. Company Details
9.20.2 Moderna, Inc. Description and Business Overview
9.20.3 Moderna, Inc. Novel Coronavirus (COVID-19) Vaccine Introduction
9.20.4 Moderna, Inc. Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2020-2021)
9.20.5 Moderna, Inc. Recent Development
9.21 Curevac
9.21.1 Curevac Company Details
9.21.2 Curevac Description and Business Overview
9.21.3 Curevac Novel Coronavirus (COVID-19) Vaccine Introduction
9.21.4 Curevac Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2020-2021)
9.21.5 Curevac Recent Development
9.22 ImmunoPrecise
9.22.1 ImmunoPrecise Company Details
9.22.2 ImmunoPrecise Description and Business Overview
9.22.3 ImmunoPrecise Novel Coronavirus (COVID-19) Vaccine Introduction
9.22.4 ImmunoPrecise Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2020-2021)
9.22.5 ImmunoPrecise Recent Development
10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
List of Tables
Table 1. Global Novel Coronavirus (COVID-19) Vaccine Market Size Growth Rate by Type (2021-2027) (US$ Million)
Table 2. Key Players of DNA
Table 3. Key Players of RNA
Table 4. Key Players of Others
Table 5. Global Novel Coronavirus (COVID-19) Vaccine Market Size Growth by Application (2021-2027) (US$ Million)
Table 6. Global Novel Coronavirus (COVID-19) Vaccine Market Size by Regions (2021-2027) (US$ Million)
Table 7. Global Novel Coronavirus (COVID-19) Vaccine Market Share by Regions (2021-2027)
Table 8. Market Top Trends
Table 9. Market Use Cases
Table 10. Global Novel Coronavirus (COVID-19) Vaccine Revenue by Players (2020-2021) (US$ Million)
Table 11. Global Novel Coronavirus (COVID-19) Vaccine Market Share by Players (2020-2021)
Table 12. Key Players Headquarters and Area Served
Table 13. Key Players Novel Coronavirus (COVID-19) Vaccine Product Solution and Service
Table 14. Date of Enter into Novel Coronavirus (COVID-19) Vaccine Market
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2021-2027) (US$ Million)
Table 17. Global Novel Coronavirus (COVID-19) Vaccine Market Size Share by Type (2021-2027)
Table 18. Global Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2021-2027) (US$ Million)
Table 19. Global Novel Coronavirus (COVID-19) Vaccine Market Size Share by Application (2021-2027)
Table 20. North America Key Players Novel Coronavirus (COVID-19) Vaccine Revenue (2020-2021) (US$ Million)
Table 21. North America Key Players Novel Coronavirus (COVID-19) Vaccine Market Share (2020-2021)
Table 22. North America Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2021-2027) (US$ Million)
Table 23. North America Novel Coronavirus (COVID-19) Vaccine Market Share by Type (2021-2027)
Table 24. North America Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2021-2027) (US$ Million)
Table 25. North America Novel Coronavirus (COVID-19) Vaccine Market Share by Application (2021-2027)
Table 26. Europe Key Players Novel Coronavirus (COVID-19) Vaccine Revenue (2020-2021) (US$ Million)
Table 27. Europe Key Players Novel Coronavirus (COVID-19) Vaccine Market Share (2020-2021)
Table 28. Europe Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2021-2027) (US$ Million)
Table 29. Europe Novel Coronavirus (COVID-19) Vaccine Market Share by Type (2021-2027)
Table 30. Europe Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2021-2027) (US$ Million)
Table 31. Europe Novel Coronavirus (COVID-19) Vaccine Market Share by Application (2021-2027)
Table 32. Japan Key Players Novel Coronavirus (COVID-19) Vaccine Revenue (2020-2021) (US$ Million)
Table 33. Japan Key Players Novel Coronavirus (COVID-19) Vaccine Market Share (2020-2021)
Table 34. Japan Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2021-2027) (US$ Million)
Table 35. Japan Novel Coronavirus (COVID-19) Vaccine Market Share by Type (2021-2027)
Table 36. Japan Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2021-2027) (US$ Million)
Table 37. Japan Novel Coronavirus (COVID-19) Vaccine Market Share by Application (2021-2027)
Table 38. Key Players in China
Table 39. Key Players in Southeast Asia
Table 40. Key Players in India
Table 41. Inovio Pharmaceuticals Company Details
Table 42. Inovio Pharmaceuticals Description and Business Overview
Table 43. Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine Product
Table 44. Inovio Pharmaceuticals Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2020 and 2021
Table 45. Inovio Pharmaceuticals Recent Development
Table 46. Takis Biotech (Evvivax) Company Details
Table 47. Takis Biotech (Evvivax) Description and Business Overview
Table 48. Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine Product
Table 49. Takis Biotech (Evvivax) Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2020 and 2021
Table 50. Takis Biotech (Evvivax) Recent Development
Table 51. Zydus Cadila Company Details
Table 52. Zydus Cadila Description and Business Overview
Table 53. Zydus Cadila Novel Coronavirus (COVID-19) Vaccine Product
Table 54. Zydus Cadila Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2020 and 2021
Table 55. Zydus Cadila Recent Development
Table 56. Codagenix, Inc. Company Details
Table 57. Codagenix, Inc. Description and Business Overview
Table 58. Codagenix, Inc. Novel Coronavirus (COVID-19) Vaccine Product
Table 59. Codagenix, Inc. Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2020 and 2021
Table 60. Codagenix, Inc. Recent Development
Table 61. GeoVax, Inc. Company Details
Table 62. GeoVax, Inc. Description and Business Overview
Table 63. GeoVax, Inc. Novel Coronavirus (COVID-19) Vaccine Product
Table 64. GeoVax, Inc. Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2020 and 2021
Table 65. GeoVax, Inc. Recent Development
Table 66. Bravovax Company Details
Table 67. Bravovax Description and Business Overview
Table 68. Bravovax Novel Coronavirus (COVID-19) Vaccine Product
Table 69. Bravovax Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2020 and 2021
Table 70. Bravovax Recent Development
Table 71. Janssen Pharmaceutical Companies Company Details
Table 72. Janssen Pharmaceutical Companies Description and Business Overview
Table 73. Janssen Pharmaceutical Companies Novel Coronavirus (COVID-19) Vaccine Product
Table 74. Janssen Pharmaceutical Companies Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2020 and 2021
Table 75. Janssen Pharmaceutical Companies Recent Development
Table 76. Altimmune Company Details
Table 77. Altimmune Description and Business Overview
Table 78. Altimmune Novel Coronavirus (COVID-19) Vaccine Product
Table 79. Altimmune Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2020 and 2021
Table 80. Altimmune Recent Development
Table 81. Vaxart Company Details
Table 82. Vaxart Description and Business Overview
Table 83. Vaxart Novel Coronavirus (COVID-19) Vaccine Product
Table 84. Vaxart Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2020 and 2021
Table 85. Vaxart Recent Development
Table 86. CanSino Biologics Company Details
Table 87. CanSino Biologics Description and Business Overview
Table 88. CanSino Biologics Novel Coronavirus (COVID-19) Vaccine Product
Table 89. CanSino Biologics Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2020 and 2021
Table 90. CanSino Biologics Recent Development
Table 91. ExpreS2ion Biotechnologies ApS Company Details
Table 92. ExpreS2ion Biotechnologies ApS Description and Business Overview
Table 93. ExpreS2ion Biotechnologies ApS Novel Coronavirus (COVID-19) Vaccine Product
Table 94. ExpreS2ion Biotechnologies ApS Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2020 and 2021
Table 95. ExpreS2ion Biotechnologies ApS Recent Development
Table 96. Clover Biopharmaceuticals Company Details
Table 97. Clover Biopharmaceuticals Description and Business Overview
Table 98. Clover Biopharmaceuticals Novel Coronavirus (COVID-19) Vaccine Product
Table 99. Clover Biopharmaceuticals Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2020 and 2021
Table 100. Clover Biopharmaceuticals Recent Development
Table 101. GSK Company Details
Table 102. GSK Description and Business Overview
Table 103. GSK Novel Coronavirus (COVID-19) Vaccine Product
Table 104. GSK Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2020 and 2021
Table 105. GSK Recent Development
Table 106. Vaxil Bio Ltd. Company Details
Table 107. Vaxil Bio Ltd. Description and Business Overview
Table 108. Vaxil Bio Ltd. Novel Coronavirus (COVID-19) Vaccine Product
Table 109. Vaxil Bio Ltd. Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2020 and 2021
Table 110. Vaxil Bio Ltd. Recent Development
Table 111. Generex Company Details
Table 112. Generex Description and Business Overview
Table 113. Generex Novel Coronavirus (COVID-19) Vaccine Product
Table 114. Generex Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2020 and 2021
Table 115. Generex Recent Development
Table 116. Novavax, Inc. Company Details
Table 117. Novavax, Inc. Description and Business Overview
Table 118. Novavax, Inc. Novel Coronavirus (COVID-19) Vaccine Product
Table 119. Novavax, Inc. Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2020 and 2021
Table 120. Novavax, Inc. Recent Development
Table 121. Sanofi Pasteur Company Details
Table 122. Sanofi Pasteur Description and Business Overview
Table 123. Sanofi Pasteur Novel Coronavirus (COVID-19) Vaccine Product
Table 124. Sanofi Pasteur Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2020 and 2021
Table 125. Sanofi Pasteur Recent Development
Table 126. Baylor Company Details
Table 127. Baylor Description and Business Overview
Table 128. Baylor Novel Coronavirus (COVID-19) Vaccine Product
Table 129. Baylor Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2020 and 2021
Table 130. Baylor Recent Development
Table 131. iBio, Inc. Company Details
Table 132. iBio, Inc. Description and Business Overview
Table 133. iBio, Inc. Novel Coronavirus (COVID-19) Vaccine Product
Table 134. iBio, Inc. Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2020 and 2021
Table 135. iBio, Inc. Recent Development
Table 136. Moderna, Inc. Company Details
Table 137. Moderna, Inc. Description and Business Overview
Table 138. Moderna, Inc. Novel Coronavirus (COVID-19) Vaccine Product
Table 139. Moderna, Inc. Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2020 and 2021
Table 140. Moderna, Inc. Recent Development
Table 141. Curevac Company Details
Table 142. Curevac Description and Business Overview
Table 143. Curevac Novel Coronavirus (COVID-19) Vaccine Product
Table 144. Curevac Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2020 and 2021
Table 145. Curevac Recent Development
Table 146. ImmunoPrecise Company Details
Table 147. ImmunoPrecise Description and Business Overview
Table 148. ImmunoPrecise Novel Coronavirus (COVID-19) Vaccine Product
Table 149. ImmunoPrecise Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2020 and 2021
Table 150. ImmunoPrecise Recent Development
Table 151. Novel Coronavirus (COVID-19) Vaccine Market Trends
Table 152. Novel Coronavirus (COVID-19) Vaccine Market Drivers
Table 153. Novel Coronavirus (COVID-19) Vaccine Market Challenges
Table 154. Novel Coronavirus (COVID-19) Vaccine Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Novel Coronavirus (COVID-19) Vaccine Market Share by Type in 2021 & 2027
Figure 2. DNA Features
Figure 3. RNA Features
Figure 4. Others Features
Figure 5. Global Novel Coronavirus (COVID-19) Vaccine Market Share by Application in 2021 & 2027
Figure 6. Mild Symptom Patient Case Studies
Figure 7. Critically Ill Patient Case Studies
Figure 8. Novel Coronavirus (COVID-19) Vaccine Report Years Considered
Figure 9. Global Novel Coronavirus (COVID-19) Vaccine Market Size and Growth Rate (2020-2027) (US$ Million)
Figure 10. Global Novel Coronavirus (COVID-19) Vaccine Market Share by Regions (2020-2027)
Figure 11. Global Novel Coronavirus (COVID-19) Vaccine Market Share by Players in 2021
Figure 12. Global Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Type (2021-2027)
Figure 13. Global Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Application (2021-2027)
Figure 14. Global Novel Coronavirus (COVID-19) Vaccine Revenue Market Share by Application in 2021
Figure 15. North America Novel Coronavirus (COVID-19) Vaccine Market Size 2021-2027 (US$ Million)
Figure 16. Europe Novel Coronavirus (COVID-19) Vaccine Market Size 2021-2027 (US$ Million)
Figure 17. Japan Novel Coronavirus (COVID-19) Vaccine Market Size 2021-2027 (US$ Million)
Figure 18. Novel Coronavirus (COVID-19) Vaccine Market Size in China (2021-2027) (US$ Million)
Figure 19. Novel Coronavirus (COVID-19) Vaccine Market Size in Southeast Asia (2021-2027) (US$ Million)
Figure 20. Novel Coronavirus (COVID-19) Vaccine Market Size in India (2021-2027) (US$ Million)
Figure 21. Bottom-up and Top-down Approaches for This Report
Figure 22. Data Triangulation
Figure 23. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Single Mode Lasers Market Insights and Forecast to 2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 136

The global market for Single Mode Lasers was estimated at US$ 975.12 million in the year 2022, is projected to reach a revised size of US$ 1,709.77 million by 2029, growing at a CAGR of 8.69 % during the forecast period 2023-2029. North American market for Single Mode Lasers was valued at $ 165.28 million in 2022 and will reach $ 271.51 million by 2029, at a CAGR of 7.50 % during the forecast period of 2023 through 2029. Asia-Pacific market for Single Mode Lasers was valued at $ 59......

Global RF Power Supply for Semiconductor Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 4850 Onwards        Pages: 193

The global market for RF Power Supply for Semiconductor was estimated at US$ 1012 million in the year 2022, is projected to reach a revised size of US$ 1323 million by 2029, growing at a CAGR of 6.16% during the forecast period 2023-2029. North American market for RF Power Supply for Semiconductor was valued at $ 220 million in 2022 and will reach $ 282 million by 2029, at a CAGR of 5.85% during the forecast period of 2023 through 2029. Asia-Pacific market for RF Power Supply for S......

Global Non-Contact Dynamic Torque Sensor Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 198

The global market for Non-Contact Dynamic Torque Sensor was estimated at US$ 58.31 million in the year 2022, is projected to reach a revised size of US$ 96.9 million by 2029, growing at a CAGR of 7.81% during the forecast period 2023-2029. North American market for Non-Contact Dynamic Torque Sensor was valued at $ 23.56 million in 2022 and will reach $ 37.86 million by 2029, at a CAGR of 7.27% during the forecast period of 2023 through 2029. Asia-Pacific market for Non-Contact Dyna......

Global Bitcoin Miner Market Research Report 2023

Published: 11-Jan-2024        Price: US 2900 Onwards        Pages: 144

The global Bitcoin Miner market was valued at US$ 11,546.70 million in 2022 and is expected to reach US$ 23,842.76 million by the end of 2029, growing at a CAGR of 26.7% between 2023 and 2029. The demand for Bitcoin Miner depends on various factors such as the current Bitcoin price, mining difficulty, and availability of newer and more efficient ASIC miners. When Bitcoin prices rise, there is usually an increase in demand for mining hardware as miners seek to increase their profits......

Global Brushless AC Motor Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 103

The global Brushless AC Motor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Brushless AC Motor is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Brushless AC Motor is estimated to increase from $ million in 2023 to reach $ million by 2......

Global High Intensity Discharge (HID) Lamps Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 116

The global High Intensity Discharge (HID) Lamps market was valued at US$ 6405.5 million in 2023 and is anticipated to reach US$ 7607.6 million by 2030, witnessing a CAGR of 2.5% during The forecast period 2024-2030. North American market for High Intensity Discharge (HID) Lamps is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for High Intensity Discharge (HID) Lamps ......

Global Indoor Plant Lighting Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 114

The global Indoor Plant Lighting market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1137.9 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. Indoor plant lighting refers to The use of artificial light sources to provide The necessary light spectrum for The growth of plants indoors, especially in environments where natural sunlight is limited. This is commonly used for growing plants like houseplants, herbs, and even some veget......

Global Aquarium Lights Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 131

The global Aquarium Lights market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Aquarium Lights is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Aquarium Lights is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global LED Aquarium Lighting Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 128

Aquarium light is also called water plants grow light, which is a new emerging light tool instead of sunshine in The last 5 years. According to The law of water plant growth, aquarium light can meet The light needs of many water plants. What's more, this lighting tool can provide The best lighting solution for aquarium, fish view. The global LED Aquarium Lighting market was valued at US$ 200 million in 2023 and is anticipated to reach US$ 283.4 million by 2030, witnessing a CAGR of ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs